Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Boston Scientific Stock Quote

Boston Scientific (NYSE: BSX)

Price as of April 17, 2024, 1:24 p.m. ET

Boston Scientific Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
BSX +31.66% +94.02% +14.17% +1,491%
S&P +21.68% +73.88% +11.70% +1,113%

Boston Scientific Company Info

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

News & Analysis

The Fool has written over 300 articles on Boston Scientific.


Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.